Study #2024-1663
TRIPS - Treatment to improve depression and/or anxiety using psilocybin-assisted psychotherapy in cancer survivors
MD Anderson Study Status
Enrolling
Treatment Agent
Psilocybin
Description
This clinical research study is to learn about the feasibility, safety, and effects of psilocybin-assisted psychotherapy for cancer survivors with depression and/or anxiety.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Depression, Anxiety, Cancer
Study phase:
Phase II
Physician name:
Moran Amit
Department:
Head & Neck Surgery
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop UT MD Anderson
Show your support for our mission through branded merchandise.